FRQ — Singapore Paincare Holdings Income Statement
0.000.00%
Last trade - 00:00
- SG$25.99m
- SG$33.18m
- SG$22.08m
- 57
- 42
- 34
- 38
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.89 | 9.65 | 11 | 18.8 | 22.1 |
Cost of Revenue | |||||
Gross Profit | 3.19 | 7.45 | 8.66 | 15.7 | 18.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.48 | 7.33 | 8.38 | 13.9 | 20.7 |
Operating Profit | 1.4 | 2.32 | 2.57 | 4.95 | 1.37 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1.39 | 2.4 | 2.62 | 5.21 | 1.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.26 | 1.88 | 2.16 | 4.33 | 0.246 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.26 | 1.88 | 2.2 | 3.9 | -0.502 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.26 | 1.88 | 2.2 | 3.9 | -0.502 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.008 | 0.009 | 0.011 | 0.021 | -0.001 |
Dividends per Share |